ELUTIA INC.
Profile
Company Names
ELUTIA INC.
AZIYO BIOLOGICS, INC.
Addresses
12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD 20904
Phone Numbers
240-247-1170
240-247-1143
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$54,589,632.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-09-21
$10,500,000.00
$10,500,000.00
$0.00
Equity
5
2021-12-05
$13,999,975.00
$13,999,975.00
$0.00
Equity
4
2020-09-11
$5,039,427.00
$5,039,427.00
$0.00
Equity
3
2019-12-13
$3,050,230.00
$3,500,000.00
$449,770.00
Equity
2
2018-07-25
$10,000,000.00
$10,000,000.00
$0.00
Equity
1
2017-05-31
$12,000,000.00
$12,000,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
MATTHEW
FERGUSON
EXECUTIVE OFFICER
STEVEN
HOCHBERG
DIRECTOR
OUROBOROS MEDICAL INC
| SOLAR CAPITAL LTD.
| ACUTUS MEDICAL, INC.
| SENTREHEART INC
| BREATHE TECHNOLOGIES, INC.
| PQ BYPASS, INC.
| AXON THERAPIES INC.
| SPECTRAWAVE, INC.
| CONVENTUS ORTHOPAEDICS INC
| LIQUID WIRE INC.
| ARTMS INC.
| AZIYO BIOLOGICS, INC.
| NXT BIOMEDICAL, LLC
| SLR HC BDC LLC
| HEARME IN 30 INC
| SLR PRIVATE CREDIT BDC II LLC
| LW HOLDCO LLC
KEVIN
RAKIN
DIRECTOR
HELIX THERAPEUTICS, LLC
| HELIX THERAPEUTICS, INC.
| CYVEK, INC.
| HISTOGENICS CORP
| CHEETAH MEDICAL, INC.
| HIGHCAPE PARTNERS QP, L.P.
| HIGHCAPE PARTNERS, L.P.
| TELA BIO, INC.
| CYOMICS, LLC
| AZIYO BIOLOGICS, INC.
| CYBREXA HOLDING COMPANY, LLC
| CONVEXITY SCIENTIFIC INC.
| HIGHCAPE PARTNERS II, L.P.
| HIGHCAPE PARTNERS QP II, L.P.
| HIGHCAPE PARTNERS II QSI INVEST, L.P.
| ELUTIA PIPE INVESTMENT, LP
| ELUTIA INC.
| ALPHINA THERAPEUTICS, INC.
WILLIAM
MATTHEW
ZUGA
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2023-09-21
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2021-12-05
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-09-11
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

